A. O’Neill

1.9k total citations
26 papers, 1.4k citations indexed

About

A. O’Neill is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, A. O’Neill has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in A. O’Neill's work include Estrogen and related hormone effects (6 papers), Glioma Diagnosis and Treatment (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). A. O’Neill is often cited by papers focused on Estrogen and related hormone effects (6 papers), Glioma Diagnosis and Treatment (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). A. O’Neill collaborates with scholars based in United States, Netherlands and Poland. A. O’Neill's co-authors include Stuart A. Grossman, Kathryn A. Carson, Tracy T. Batchelor, Fred H. Hochberg, Pamela New, Jane Β. Alavi, Daniel F. Hayes, Rebecca Gelman, Walter P. Carney and Hideko Yamauchi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

A. O’Neill

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. O’Neill United States	12	579	495	438	415	381	26	1.4k
Brian Thiessen Canada	16	687 1.2×	220 0.4×	261 0.6×	412 1.0×	128 0.3×	32	1.2k
Sergey Popov United Kingdom	20	358 0.6×	316 0.6×	169 0.4×	825 2.0×	173 0.5×	48	1.5k
Lynn S. Ashby United States	20	1.1k 1.8×	208 0.4×	348 0.8×	304 0.7×	88 0.2×	46	1.6k
Kenji Tada Japan	15	639 1.1×	284 0.6×	134 0.3×	829 2.0×	242 0.6×	23	1.7k
Regina Fillbrandt Germany	13	499 0.9×	294 0.6×	108 0.2×	807 1.9×	171 0.4×	15	1.4k
Andrey Golanov Russia	22	1.0k 1.8×	266 0.5×	426 1.0×	622 1.5×	79 0.2×	162	1.7k
Lori Frederick United States	15	646 1.1×	523 1.1×	117 0.3×	1.1k 2.7×	264 0.7×	22	1.7k
H. S. Friedman United States	21	969 1.7×	627 1.3×	454 1.0×	907 2.2×	221 0.6×	50	2.4k
Nathalie Baeza France	17	887 1.5×	431 0.9×	117 0.3×	1.2k 2.8×	128 0.3×	28	2.2k
D D Bigner United States	19	423 0.7×	399 0.8×	206 0.5×	461 1.1×	59 0.2×	24	1.3k

Countries citing papers authored by A. O’Neill

Since Specialization

Citations

This map shows the geographic impact of A. O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. O’Neill more than expected).

Fields of papers citing papers by A. O’Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. O’Neill. The network helps show where A. O’Neill may publish in the future.

Co-authorship network of co-authors of A. O’Neill

This figure shows the co-authorship network connecting the top 25 collaborators of A. O’Neill. A scholar is included among the top collaborators of A. O’Neill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. O’Neill. A. O’Neill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pai, Shweta, Ashok Muniappan, Aaron D. Friedman, et al.. (2024). 992O Pembrolizumab for HPV-associated recurrent respiratory papillomatosis. Annals of Oncology. 35. S676–S676. 2 indexed citations

Casado‐Medrano, Victoria, A. O’Neill, Julio C. Ricarte‐Filho, et al.. (2023). Development of Novel Murine BRAFV600E-Driven Papillary Thyroid Cancer Cell Lines for Modeling of Disease Progression and Preclinical Evaluation of Therapeutics. Cancers. 15(3). 879–879. 2 indexed citations

Casado‐Medrano, Victoria, et al.. (2022). NTRK-fusions in pediatric thyroid tumors: Current state and future perspectives. Cancer Genetics. 264-265. 23–28. 4 indexed citations

Ricarte‐Filho, Julio C., A. O’Neill, Victoria Casado‐Medrano, et al.. (2022). The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer. Cancer Genetics. 262-263. 57–63. 16 indexed citations

Patnaik, Amita, Inderjit Mehmi, James Strauss, et al.. (2021). 135P First-in-human phase I trial of SRF617, a potent inhibitor of CD39 activity, as monotherapy or in combination, in patients (pts) with advanced solid tumors. Annals of Oncology. 32. S1435–S1436. 6 indexed citations

Hamilton, E.P., Neelima Vidula, P. LoRusso, et al.. (2019). Abstract OT1-02-02: A phase 1, first-in-human, multi-part study of RAD140, an oral nonsteroidal selective androgen receptor modulator, in postmenopausal women with hormone receptor positive breast cancer. Cancer Research. 79(4_Supplement). OT1–2. 1 indexed citations

Vries, Elisabeth G.E. de, Andor W.J.M. Glaudemans, Agnes Jager, et al.. (2018). Abstract P1-10-04: Elacestrant, a novel oral selective estrogen receptor degrader (SERD), decreases tumoral 18F-FES uptake in a phase 1 study of ER+, HER2 -, advanced breast cancer patients. Cancer Research. 78(4_Supplement). P1–10. 1 indexed citations

Glaudemans, Andor W.J.M., et al.. (2017). Abstract P2-08-08: A phase 1 study of RAD1901, an oral selective estrogen receptor degrader, to determine changes in the 18F-FES uptake and tumor responses in ER-positive, HER2-negative, advanced breast cancer patients. Cancer Research. 77(4_Supplement). P2–8. 3 indexed citations

O’Neill, A., C. Lyons, Satish Kumar Jain, Alan R. Hounsell, & Joe M. O’Sullivan. (2016). EP-2110: A study of prostatic calculi: in patients receiving radical radiotherapy for prostate cancer. Radiotherapy and Oncology. 119. S992–S992. 2 indexed citations

10.

Ettaro, Lorraine, et al.. (2016). DOD Renewable Energy Projects: Improved Guidance Needed for Analyzing and Documenting Costs and Benefits. 4 indexed citations

11.

Watson, R. William G., et al.. (2015). Persistent systemic monocyte and neutrophil activation in neonatal encephalopathy. The Journal of Maternal-Fetal & Neonatal Medicine. 29(4). 582–589. 22 indexed citations

12.

O’Neill, A., Brittany Bahamón, David C. Alsop, et al.. (2013). Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts. British Journal of Cancer. 108(2). 319–326. 34 indexed citations

13.

O’Neill, A., Nilay Shah, Naamah Zitomersky, et al.. (2013). Insulin-Like Growth Factor 1 Receptor as a Therapeutic Target in Ewing Sarcoma: Lack of Consistent Upregulation or Recurrent Mutation and a Review of the Clinical Trial Literature. Sarcoma. 2013. 1–12. 19 indexed citations

14.

Bhatt, Rupal S., Amado J. Zurita, A. O’Neill, et al.. (2011). Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma. British Journal of Cancer. 105(1). 112–117. 23 indexed citations

15.

Awad, Ola, Jason T. Yustein, Preeti Shah, et al.. (2010). High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition. PLoS ONE. 5(11). e13943–e13943. 121 indexed citations

16.

Reardon, David A., Karen Fink, Tom Mikkelsen, et al.. (2008). Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme. Journal of Clinical Oncology. 26(34). 5610–5617. 377 indexed citations

17.

Kesari, Santosh, David Schiff, Lisa Doherty, et al.. (2007). Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Neuro-Oncology. 9(3). 354–363. 92 indexed citations

18.

Batchelor, Tracy T., Kathryn A. Carson, A. O’Neill, et al.. (2003). Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07. Journal of Clinical Oncology. 21(6). 1044–1049. 400 indexed citations

19.

Sledge, G. W., et al.. (2001). Pilot trial of paclitaxel-herceptin adjuvant therapy for early stage breast cancer (E2198). Breast Cancer Research and Treatment. 69(3). 4 indexed citations

20.

Yamauchi, Hideko, et al.. (1997). Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein.. Journal of Clinical Oncology. 15(7). 2518–2525. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact